CRMD Q1 2025 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$39M

Gross Profit

$37M95.9% margin

Operating Income

$20M51.5% margin

Net Income

$21M52.8% margin

EPS (Diluted)

$0.30

QoQ Revenue Growth

+25.2%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$20M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$150M

Total Liabilities

$35M

Stockholders' Equity

$115M

Cash & Equivalents

$66M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$0	—
Gross Profit	$37M	-$818,539	+4679.5%
Operating Income	$20M	-$17M	+220.5%
Net Income	$21M	-$14M	+242.7%